7 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
- May-Thurner syndrome ... Recurrent #DVT #VTE ... #anticoagulation ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Thrombosis and Management ... Algorithm #Anticoagulation ... #Extension #VTE ... #DVT #Hematology ... #Differential #
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Spontaneous • Calf ... post-thrombotic syndrome ... DeLoughery @Bloodman #VTE ... #anticoagulation ... #duration #management
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
verrucous) • Lung ... Cerebral > Splenic, pulmonary ... Marantic (NTBE) Differential ... cause + Systemic anticoagulation ... Endocarditis #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE ... unless prior heart/lung ... medical and surgical management
Endocarditis - Overview and Differential Diagnosis Framework

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV
- Overview and Differential ... , verrucous) - Lung ... Cerebral > Splenic, Pulmonary ... Cholesterol emboli syndrome ... cause + Systemic anticoagulation